Non-GLP peptides Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
15:08
Mar 09
Mar 09
Peptide therapeutics going mainstream.
Non-GLP peptides like BPC-157, Pinealon, growth hormone secretagogues (tesamorelin, ipamorelin, sermorelin, MK-677), and melanotan are already widely used through compounding, gray, and black markets. The horse is out of the stable; in five years, people will take peptide cocktails for sleep, dopamine, micronutrients, and Alzheimer's protection, making peptide therapeutics mainstream.
HIGH
About Non-GLP peptides Investor Commentary
Across the available history and selected sources, Buzzberg tracks Non-GLP peptides across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Andrew Huberman.